These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9766857)

  • 1. Drug accumulation in melanin: an affinity chromatographic study.
    Knörle R; Schniz E; Feuerstein TJ
    J Chromatogr B Biomed Sci Appl; 1998 Sep; 714(2):171-9. PubMed ID: 9766857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applications of affinity chromatography to the study of drug-melanin binding interactions.
    Aubry AF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Feb; 768(1):67-74. PubMed ID: 11939559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Throughput Melanin-Binding Affinity and In Silico Methods to Aid in the Prediction of Drug Exposure in Ocular Tissue.
    Reilly J; Williams SL; Forster CJ; Kansara V; End P; Serrano-Wu MH
    J Pharm Sci; 2015 Dec; 104(12):3997-4001. PubMed ID: 26524700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of drug binding to melanin using a melanin-based high-performance liquid chromatographic stationary phase and chemometric analysis of the chromatographic data.
    Kaliszan R; Kaliszan A; Wainer IW
    J Chromatogr; 1993 Jun; 615(2):281-8. PubMed ID: 8335705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a melanin-based high-performance liquid chromatography stationary phase and its use in the study of drug-melanin binding interactions.
    Ibrahim H; Aubry AF
    Anal Biochem; 1995 Aug; 229(2):272-7. PubMed ID: 7485982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatographic modelling of interactions between melanin and phenothiazine and dibenzazepine drugs.
    Radwańska A; Frackowiak T; Ibrahim H; Aubry AF; Kaliszan R
    Biomed Chromatogr; 1995; 9(5):233-7. PubMed ID: 8593425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Phototoxicity Testing Strategy for Accurate Photosafety Evaluation of Pharmaceuticals Based on the Assessment of Possible Melanin-Binding Effects.
    Reinen J; van Sas P; van Huygevoort T; Rubio L; Scase K; Wenker M
    Int J Toxicol; 2018; 37(4):296-307. PubMed ID: 29898631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Affinity of ocular acid-insoluble melanin for drugs in vitro.
    Tsuchiya M; Hayasaka S; Mizuno K
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):822-5. PubMed ID: 3570692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic beads method for determination of binding of drugs to melanin.
    Marszałł MP; Buciński A; Goryński K; Proszowska A; Kaliszan R
    J Chromatogr A; 2011 Jan; 1218(2):229-36. PubMed ID: 21144529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanin binding study of clinical drugs with cassette dosing and rapid equilibrium dialysis inserts.
    Pelkonen L; Tengvall-Unadike U; Ruponen M; Kidron H; Del Amo EM; Reinisalo M; Urtti A
    Eur J Pharm Sci; 2017 Nov; 109():162-168. PubMed ID: 28756205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of drugs to eye melanin is not predictive of ocular toxicity.
    Leblanc B; Jezequel S; Davies T; Hanton G; Taradach C
    Regul Toxicol Pharmacol; 1998 Oct; 28(2):124-32. PubMed ID: 9927562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.
    Pescina S; Santi P; Ferrari G; Padula C; Cavallini P; Govoni P; Nicoli S
    Eur J Pharm Sci; 2012 Aug; 46(5):475-83. PubMed ID: 22484210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calculation of drug-melanin binding energy using molecular modeling.
    Raghavan PR; Zane PA; Tripp SL
    Experientia; 1990 Jan; 46(1):77-80. PubMed ID: 2298284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-performance affinity chromatography and immobilized serum albumin as probes for drug- and hormone-protein binding.
    Hage DS; Austin J
    J Chromatogr B Biomed Sci Appl; 2000 Feb; 739(1):39-54. PubMed ID: 10744312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of drug-binding to melanin.
    Larsson B; Tjälve H
    Biochem Pharmacol; 1979 Apr; 28(7):1181-7. PubMed ID: 36092
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of competitive binding of enantiomers to protein by affinity capillary electrochromatography.
    Ye M; Zou H; Liu Z; Wu R; Lei Z; Ni J
    J Pharm Biomed Anal; 2002 Jan; 27(3-4):651-60. PubMed ID: 11755765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetrable silica microspheres for immobilization of bovine serum albumin and their application to the study of the interaction between imatinib mesylate and protein by frontal affinity chromatography.
    Ma L; Li J; Zhao J; Liao H; Xu L; Shi ZG
    Anal Bioanal Chem; 2016 Jan; 408(3):805-14. PubMed ID: 26573171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary-scale frontal affinity chromatography/MALDI tandem mass spectrometry using protein-doped monolithic silica columns.
    Kovarik P; Hodgson RJ; Covey T; Brook MA; Brennan JD
    Anal Chem; 2005 May; 77(10):3340-50. PubMed ID: 15889927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The melanin binding of drugs and its implications.
    Ings RM
    Drug Metab Rev; 1984; 15(5-6):1183-212. PubMed ID: 6396056
    [No Abstract]   [Full Text] [Related]  

  • 20. High-Performance Affinity Chromatography: Applications in Drug-Protein Binding Studies and Personalized Medicine.
    Li Z; Beeram SR; Bi C; Suresh D; Zheng X; Hage DS
    Adv Protein Chem Struct Biol; 2016; 102():1-39. PubMed ID: 26827600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.